{"id":"covid-19-exposure","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL5314794","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It does this by activating immune cells to produce a strong response against the virus, helping to prevent severe illness and reduce the risk of hospitalization.","oneSentence":"This drug aims to stimulate the immune system to fight COVID-19 infection.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:29:10.321Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of COVID-19 disease caused by SARS-CoV-2 virus"}]},"trialDetails":[{"nctId":"NCT04418206","phase":"NA","title":"Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2020-06-01","conditions":"Covid 19","enrollment":950},{"nctId":"NCT05677932","phase":"NA","title":"Bright Light Therapy for Post-COVID-19 Fatigue","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2023-02-15","conditions":"Post COVID-19 Condition","enrollment":12},{"nctId":"NCT05886816","phase":"PHASE2","title":"Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-03-01","conditions":"SARS-CoV Infection, COVID-19","enrollment":112},{"nctId":"NCT06082518","phase":"NA","title":"Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2024-01-02","conditions":"Post COVID-19 Condition, Post-COVID-19 Syndrome, Post-COVID Syndrome","enrollment":40},{"nctId":"NCT05876377","phase":"","title":"Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2023-10-23","conditions":"SARS-CoV-2, COVID-19, Post-Acute COVID-19 Syndrome","enrollment":1},{"nctId":"NCT01306084","phase":"","title":"Viral Infections in Healthy and Immunocompromised Hosts","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-03-15","conditions":"Anogenital Herpes, COVID-19, Herpes Labialis","enrollment":1000},{"nctId":"NCT07464561","phase":"NA","title":"RESCCUE4 - Group CBT for Social Anxiety in Adolescents","status":"COMPLETED","sponsor":"Bambino Gesù Hospital and Research Institute","startDate":"2024-05-01","conditions":"Social Anxiety Disorder","enrollment":34},{"nctId":"NCT05040659","phase":"","title":"Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2022-11-14","conditions":"Anosmia, Asymptomatic COVID-19, COVID-19 Respiratory Infection","enrollment":1000},{"nctId":"NCT04403386","phase":"","title":"Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19","status":"COMPLETED","sponsor":"National Institute of Environmental Health Sciences (NIEHS)","startDate":"2020-06-01","conditions":"COVID-19","enrollment":132},{"nctId":"NCT05954286","phase":"PHASE2","title":"PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19","status":"COMPLETED","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2024-01-29","conditions":"SARS-CoV-2","enrollment":92},{"nctId":"NCT06159699","phase":"","title":"Telecommunication Technology-based Online Survey","status":"RECRUITING","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2022-12-02","conditions":"Risk Factors, Polypharmacy, Drug Interactions","enrollment":2000},{"nctId":"NCT04582903","phase":"","title":"Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2020-10-13","conditions":"COVID-19 Infection","enrollment":5000},{"nctId":"NCT04500600","phase":"","title":"Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-06-11","conditions":"COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm","enrollment":13378},{"nctId":"NCT04481633","phase":"NA","title":"Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2020-09-09","conditions":"COVID-19","enrollment":552},{"nctId":"NCT04442048","phase":"PHASE3","title":"Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure","status":"COMPLETED","sponsor":"Canadian Cancer Trials Group","startDate":"2020-10-01","conditions":"Cancer, Covid-19","enrollment":195},{"nctId":"NCT04659759","phase":"","title":"COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2020-11-17","conditions":"Covid19","enrollment":105},{"nctId":"NCT06168019","phase":"","title":"Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India","status":"RECRUITING","sponsor":"Boston University","startDate":"2023-12-26","conditions":"Influenza, COVID-19, SARS-COV-2 Infection","enrollment":10000},{"nctId":"NCT04344379","phase":"PHASE3","title":"Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-04-17","conditions":"SARS-CoV-2 Infection","enrollment":122},{"nctId":"NCT04885530","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2021-06-08","conditions":"Covid19","enrollment":10956},{"nctId":"NCT04610515","phase":"","title":"Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2020-12-15","conditions":"Covid19, ME/CFS, SARS COV2","enrollment":6000},{"nctId":"NCT05425264","phase":"NA","title":"Home-Based Exercise Tele-Rehabilitation After COVID-19","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-06-29","conditions":"Post SARS-CoV2 (COVID-19)","enrollment":80},{"nctId":"NCT06614309","phase":"NA","title":"Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-09-24","conditions":"Long COVID","enrollment":45},{"nctId":"NCT06703190","phase":"","title":"Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine","status":"TERMINATED","sponsor":"Pfizer","startDate":"2024-11-25","conditions":"COVID-19","enrollment":1},{"nctId":"NCT06325332","phase":"","title":"BEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study)","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2024-04-01","conditions":"Respiratory Syncytial Virus","enrollment":49680},{"nctId":"NCT04887116","phase":"EARLY_PHASE1","title":"Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2023-10-05","conditions":"Posttraumatic Stress Disorder","enrollment":20},{"nctId":"NCT05074433","phase":"PHASE3","title":"A Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults","status":"TERMINATED","sponsor":"Regeneron Pharmaceuticals","startDate":"2021-10-25","conditions":"Immunocompromised","enrollment":66},{"nctId":"NCT04650178","phase":"","title":"Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-05-26","conditions":"COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm","enrollment":274},{"nctId":"NCT07213596","phase":"NA","title":"Virtual Reality Treatment for Trauma Related to COVID-19 Infection","status":"NOT_YET_RECRUITING","sponsor":"Soonchunhyang University Hospital","startDate":"2025-11-01","conditions":"PTSD, PTSD Symptoms","enrollment":100},{"nctId":"NCT06647654","phase":"","title":"Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2024-08-26","conditions":"Respiratory Syncytial Virus, Respiratory Tract Diseases","enrollment":1},{"nctId":"NCT05295290","phase":"PHASE4","title":"A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.","status":"RECRUITING","sponsor":"Pfizer","startDate":"2022-11-21","conditions":"Myocarditis","enrollment":300},{"nctId":"NCT04705116","phase":"","title":"COVID-19 Vaccines International Pregnancy Exposure Registry","status":"RECRUITING","sponsor":"Pregistry","startDate":"2021-06-01","conditions":"Covid19","enrollment":6000},{"nctId":"NCT05013632","phase":"","title":"COVID-19 International Drug Pregnancy Registry","status":"RECRUITING","sponsor":"Pregistry","startDate":"2021-12-01","conditions":"Covid19","enrollment":2000},{"nctId":"NCT05109611","phase":"PHASE3","title":"Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection","status":"TERMINATED","sponsor":"Sanotize Research and Development corp.","startDate":"2021-11-20","conditions":"SARS-CoV-2 Infection","enrollment":1389},{"nctId":"NCT05813652","phase":"","title":"Relative Impacts on Preventative Primary Care--a Longitudinal Evaluation of COVID-19:Phase 1","status":"COMPLETED","sponsor":"McMaster University","startDate":"2022-10-05","conditions":"Diabetes Mellitus, Congestive Heart Failure, Chronic Kidney Diseases","enrollment":919928},{"nctId":"NCT06698497","phase":"NA","title":"Boosting COVID-19 Vaccination Uptake Using Wastewater Surveillance","status":"COMPLETED","sponsor":"Syracuse University","startDate":"2024-09-13","conditions":"Vaccine Uptake","enrollment":40},{"nctId":"NCT04397328","phase":"PHASE3","title":"COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada","status":"WITHDRAWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2020-05-30","conditions":"COVID-19","enrollment":""},{"nctId":"NCT04405271","phase":"PHASE3","title":"TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)","status":"TERMINATED","sponsor":"Hospital Italiano de Buenos Aires","startDate":"2020-07-31","conditions":"Healthcare Workers, COVID-19, SARS-CoV 2","enrollment":1378},{"nctId":"NCT05035420","phase":"NA","title":"A Noninvasive Multimodal Biosensing Device for Screening and Monitoring Response to Treatment of Infectious Respiratory Diseases","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2022-05-26","conditions":"COVID-19, Upper Respiratory Infection, Lower Respiratory Infection","enrollment":40},{"nctId":"NCT05249868","phase":"","title":"Impact of the COVID-19 Pandemic on the Health Status of People Aged 75 and Over and Their Caregivers","status":"COMPLETED","sponsor":"Gerencia de Atención Primaria, Madrid","startDate":"2022-06-01","conditions":"Aging, SARS-CoV-2 Infection, Caregivers","enrollment":1035},{"nctId":"NCT06057064","phase":"PHASE2","title":"Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-09-29","conditions":"COVID-19, SARS-CoV-2","enrollment":116},{"nctId":"NCT05655546","phase":"NA","title":"ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals","status":"TERMINATED","sponsor":"Scripps Translational Science Institute","startDate":"2022-12-22","conditions":"Immunodeficiency, Immunosuppression, HIV Infections","enrollment":2117},{"nctId":"NCT04375761","phase":"","title":"COVID-19: Human Epidemiology and Response to SARS-CoV-2","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2020-05-01","conditions":"Coronavirus Disease 2019 (COVID-19), SARS-CoV-2","enrollment":5599},{"nctId":"NCT04626050","phase":"NA","title":"General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2022-01-20","conditions":"Post-traumatic Stress Disorder, Moral Injury","enrollment":120},{"nctId":"NCT04374474","phase":"PHASE4","title":"Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)","status":"WITHDRAWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2021-01-10","conditions":"Olfactory Disorder","enrollment":""},{"nctId":"NCT06113692","phase":"","title":"A Study on the Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis After Moderna COVID-19 Vaccine","status":"COMPLETED","sponsor":"ModernaTX, Inc.","startDate":"2023-03-31","conditions":"Myocarditis, Pericarditis","enrollment":1169},{"nctId":"NCT05224076","phase":"","title":"Home Air Quality Impact for Adults With Asthma","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2022-03-30","conditions":"Asthma, Environmental Exposure, Home Environment Related Disease","enrollment":64},{"nctId":"NCT04848584","phase":"","title":"Pfizer-BioNTech COVID-19 Vaccine Effectiveness Study - Kaiser Permanente Southern California","status":"COMPLETED","sponsor":"Pfizer","startDate":"2021-05-15","conditions":"COVID-19","enrollment":1},{"nctId":"NCT05379608","phase":"NA","title":"Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection.","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2021-12-10","conditions":"COVID-19, Chronic Heart Failure, Hypertension","enrollment":43},{"nctId":"NCT04574765","phase":"","title":"A Research Platform to Screen Healthcare Workers- Coordinated Approach to Pandemic Trials of COVID-19","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2020-04-16","conditions":"Healthcare Worker, Covid19","enrollment":7373},{"nctId":"NCT05315323","phase":"","title":"Clinical Use of EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting in Gulf Cooperation Council Countries","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-06-23","conditions":"COVID-19","enrollment":550},{"nctId":"NCT04703270","phase":"","title":"Understanding COVID-19 Infection in Pregnant Women and Their Babies","status":"COMPLETED","sponsor":"St George's, University of London","startDate":"2021-01-04","conditions":"Corona Virus Infection, Pregnancy Related, Neonatal Infection","enrollment":881},{"nctId":"NCT03923452","phase":"NA","title":"Mindfulness Training for Older Adult Canadian Immigrants","status":"COMPLETED","sponsor":"Toronto Metropolitan University","startDate":"2022-06-30","conditions":"Stress","enrollment":50},{"nctId":"NCT04453969","phase":"","title":"Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a","status":"COMPLETED","sponsor":"Deborah O'Connor","startDate":"2020-05-24","conditions":"SARS-CoV2, Breastmilk","enrollment":59},{"nctId":"NCT05872958","phase":"PHASE1","title":"Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-05-19","conditions":"COVID-19","enrollment":98},{"nctId":"NCT04335084","phase":"PHASE2","title":"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection","status":"COMPLETED","sponsor":"ProgenaBiome","startDate":"2020-06-22","conditions":"COVID-19, Coronavirus Infection, Sars-CoV2","enrollment":254},{"nctId":"NCT06928480","phase":"NA","title":"Effectiveness and Acceptability of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in People With Long COVID-19.","status":"RECRUITING","sponsor":"Instituto de Investigación Sanitaria Aragón","startDate":"2025-05-01","conditions":"Long Covid-19, Emotional Disorder, Anxiety","enrollment":90},{"nctId":"NCT06968897","phase":"","title":"Neurological Development In Toddlers After Maternal SARS-CoV-2 Infection During Pregnancy","status":"ENROLLING_BY_INVITATION","sponsor":"Philipps University Marburg","startDate":"2025-04-01","conditions":"SARS CoV-2, Developmental Disorder, Pregnancy Related","enrollment":250},{"nctId":"NCT04797858","phase":"NA","title":"COVID-19 Self-Testing Through Rapid Network Distribution","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2021-05-05","conditions":"Covid19","enrollment":792},{"nctId":"NCT04682561","phase":"NA","title":"STEP: Building Trauma Resilience Among Nurses and Personal Support Workers During and Beyond COVID-19","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2022-01-01","conditions":"Stress, Trauma, Mental Health Issue","enrollment":42},{"nctId":"NCT04844541","phase":"","title":"Prophylaxis and Treatment of COVID-19","status":"COMPLETED","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2021-06-11","conditions":"COVID-19, Acute Respiratory Infection","enrollment":450},{"nctId":"NCT04672590","phase":"","title":"COVID-19 Neurological Disease: A Prospective Study","status":"COMPLETED","sponsor":"University of Liverpool","startDate":"2021-04-20","conditions":"Diseases of the Nervous System, Other Specified Viral Diseases","enrollment":1017},{"nctId":"NCT05033782","phase":"","title":"Impact of the Modifications of Environmental Exposures and Health Care Access During COVID-19 Lockdown on Multiple Sclerosis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-02-08","conditions":"Multiple Sclerosis","enrollment":1209},{"nctId":"NCT05467917","phase":"","title":"ARMOR-Household: Characterizing Transmission of COVID-19 in Households of SARS-CoV-2 Index Cases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Columbia University","startDate":"2021-08-01","conditions":"COVID-19, Households, SARS CoV 2 Infection","enrollment":374},{"nctId":"NCT05732116","phase":"","title":"PTSD of Surgeons or Anesthesiologists on Prognosis of Surgical Patients","status":"RECRUITING","sponsor":"Xijing Hospital","startDate":"2023-02-21","conditions":"Post Traumatic Stress Disorder, Postoperative Complications, COVID-19","enrollment":10000},{"nctId":"NCT04718220","phase":"NA","title":"Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2021-03-01","conditions":"Covid19, Pregnancy Related, Maternal Complication of Pregnancy","enrollment":448},{"nctId":"NCT05997290","phase":"PHASE2, PHASE3","title":"A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2023-08-10","conditions":"SARS-CoV-2 Infection, COVID-19","enrollment":1051},{"nctId":"NCT05445713","phase":"","title":"A Cross-sectional, Observational Study to Characterise Long COVID-19 in an Urban Sample of South African Adults","status":"COMPLETED","sponsor":"University of Witwatersrand, South Africa","startDate":"2022-08-10","conditions":"Long COVID","enrollment":400},{"nctId":"NCT04894435","phase":"PHASE2","title":"Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity","status":"ACTIVE_NOT_RECRUITING","sponsor":"Canadian Immunization Research Network","startDate":"2021-05-20","conditions":"COVID-19","enrollment":669},{"nctId":"NCT05648110","phase":"PHASE2, PHASE3","title":"Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-12-16","conditions":"COVID-19, SARS-CoV-2","enrollment":3882},{"nctId":"NCT05386355","phase":"NA","title":"Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool","status":"COMPLETED","sponsor":"IDeA States Pediatric Clinical Trials Network","startDate":"2022-07-18","conditions":"COVID-19 Vaccines, Telemedicine, Vaccine Hesitancy","enrollment":1934},{"nctId":"NCT04363827","phase":"PHASE2","title":"Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19)","status":"TERMINATED","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2020-05-14","conditions":"COVID19, Hydroxychloroquine, Prophylaxis","enrollment":155},{"nctId":"NCT05822193","phase":"","title":"Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil","status":"RECRUITING","sponsor":"Inova Medical","startDate":"2023-07-21","conditions":"Post-Acute COVID-19 Syndrome","enrollment":1694},{"nctId":"NCT04433260","phase":"","title":"COVID19 and Physical and Emotional Wellbeing of HCP","status":"COMPLETED","sponsor":"Queen Mary University of London","startDate":"2020-07-25","conditions":"Mental Health","enrollment":1721},{"nctId":"NCT05135650","phase":"PHASE1","title":"Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study","status":"TERMINATED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2022-01-25","conditions":"COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm","enrollment":20},{"nctId":"NCT04847479","phase":"NA","title":"COVID-19 Close Contact Self-Testing Study","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2021-05-06","conditions":"Covid19","enrollment":3},{"nctId":"NCT05553743","phase":"","title":"Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2014-03-27","conditions":"Breastfeeding, COVID-19 Infection, COVID-19 Vaccine","enrollment":5000},{"nctId":"NCT05216588","phase":"","title":"Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies with Early Access Authorization in Immunocompromised Patients. a Prospective Cohort.","status":"COMPLETED","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2022-01-26","conditions":"COVID-19, Immunocompromised Host","enrollment":149},{"nctId":"NCT05126992","phase":"","title":"EU Secondary Data Post-Authorisation Safety Study of AZD1222","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-02-18","conditions":"COVID-19, Vaccine Adverse Events of Special Interest","enrollment":5321930},{"nctId":"NCT05126589","phase":"","title":"Respiratory Virus Metagenomics After COVID-19","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2021-12-28","conditions":"COVID-19 Respiratory Infection","enrollment":500},{"nctId":"NCT05218174","phase":"NA","title":"Exercise in Adults with Post-Acute Sequelae of SARS-CoV-2 (COVID-19) Infection Study","status":"COMPLETED","sponsor":"Baylor Research Institute","startDate":"2022-04-22","conditions":"COVID-19","enrollment":21},{"nctId":"NCT05712096","phase":"","title":"eVusheld Assessment reaL wORld Effectiveness in Israel Clalit Health Services","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-03-09","conditions":"SARS-CoV-2, COVID-19","enrollment":4000},{"nctId":"NCT04625725","phase":"PHASE3","title":"Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2020-11-21","conditions":"COVID-19","enrollment":5197},{"nctId":"NCT05112900","phase":"PHASE3","title":"Health Information Technology for COVID-19 Testing in Schools (SCALE-UP Counts)","status":"COMPLETED","sponsor":"University of Utah","startDate":"2022-01-11","conditions":"COVID-19","enrollment":7122},{"nctId":"NCT05233605","phase":"","title":"Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-03-21","conditions":"Severe COVID-19","enrollment":72},{"nctId":"NCT05866211","phase":"","title":"Lung Function in Post-COVID-19 Nursing Home Residents","status":"COMPLETED","sponsor":"University of Vic - Central University of Catalonia","startDate":"2022-04-25","conditions":"Post-COVID-19 Syndrome","enrollment":184},{"nctId":"NCT05825651","phase":"","title":"Long COVID and Its Associations With Health Outcomes in Older Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peking University","startDate":"2023-04-24","conditions":"Long COVID, COVID-19 Pandemic, Elderly Infection","enrollment":11527},{"nctId":"NCT06039449","phase":"PHASE3","title":"A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2","status":"COMPLETED","sponsor":"Invivyd, Inc.","startDate":"2023-09-08","conditions":"COVID-19, SARS-CoV-2","enrollment":790},{"nctId":"NCT05580003","phase":"PHASE1","title":"A Study to Learn Safety and Blood Levels of PF-07817883 in Healthy People","status":"COMPLETED","sponsor":"Pfizer","startDate":"2022-10-17","conditions":"Healthy","enrollment":94},{"nctId":"NCT05667116","phase":"","title":"eVusheld Assessment reaL wORld Effectiveness at UPMC","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-01-09","conditions":"SARS-CoV-2, COVID-19","enrollment":4232},{"nctId":"NCT05375760","phase":"PHASE2","title":"A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2022-06-09","conditions":"Coronavirus Disease 2019 (COVID-19)","enrollment":251},{"nctId":"NCT05305651","phase":"PHASE4","title":"Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2022-07-01","conditions":"COVID-19","enrollment":217},{"nctId":"NCT05787418","phase":"PHASE3","title":"HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2","status":"ENROLLING_BY_INVITATION","sponsor":"Huahui Health","startDate":"2023-03-31","conditions":"COVID-19","enrollment":1200},{"nctId":"NCT04055376","phase":"NA","title":"Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts Institute of Technology","startDate":"2019-08-14","conditions":"Alzheimer Disease, Alzheimer Dementia","enrollment":15},{"nctId":"NCT05074953","phase":"","title":"Post-COVID-19 Monitoring in Routine Health Insurance Data","status":"COMPLETED","sponsor":"Technische Universität Dresden","startDate":"2021-08-01","conditions":"Virus Diseases, Epidemiology","enrollment":157134},{"nctId":"NCT04318444","phase":"PHASE2, PHASE3","title":"Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)","status":"TERMINATED","sponsor":"Columbia University","startDate":"2020-03-29","conditions":"COVID-19, Corona Virus Infection","enrollment":10},{"nctId":"NCT04921241","phase":"","title":"In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2021-06-08","conditions":"In Utero SARS-CoV-2 Exposure","enrollment":86},{"nctId":"NCT04684836","phase":"","title":"Comparative Effectiveness of Telemedicine in Primary Care","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2021-03-15","conditions":"Asthma, Chronic Obstructive Pulmonary Disease (COPD), Congestive Heart Failure","enrollment":33100},{"nctId":"NCT04347798","phase":"","title":"IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2020-11-01","conditions":"Covid-19 Infection, Rheumatoid Arthritis, Psoriatic Arthritis","enrollment":773},{"nctId":"NCT05569408","phase":"","title":"eVusheld Assessment reaL wORld Effectiveness in DoD Health System","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-08-10","conditions":"COVID-19; SARS-CoV-2; 2019 Novel Coronavirus Disease","enrollment":4724},{"nctId":"NCT05663957","phase":"","title":"eVusheld Assessment reaL wORld Effectiveness in the VA Health System","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-01-04","conditions":"SARS-CoV-2, COVID-19","enrollment":5814}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"COVID-19 exposure","genericName":"COVID-19 exposure","companyName":"Barts & The London NHS Trust","companyId":"barts-the-london-nhs-trust","modality":"Biologic","firstApprovalDate":"","aiSummary":"This drug aims to stimulate the immune system to fight COVID-19 infection. Used for Prevention of COVID-19 disease caused by SARS-CoV-2 virus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}